Erlotinib, gefitinib, or chemotherapy for EGFR mutation-positive lung cancer?

Lancet Oncol. 2011 Aug;12(8):710-1. doi: 10.1016/S1470-2045(11)70194-2. Epub 2011 Jul 23.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / genetics*
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • ErbB Receptors / genetics*
  • Erlotinib Hydrochloride
  • Female
  • Humans
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / therapy*
  • Male
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors